Moreover, increased levels of sCD5 have been reported in sera from patients undergoing certain autoimmune and inflammatory disorders, such as Sjögren syndrome (SS), rheumatoid arthritis, (RA) systemic inflammatory response syndrome (SIRS), and atopic dermatitis (AD), in which lymphocyte activation occurs [38,39,40,41]. Here, SCD5 is linked to rheumatoid arthritis.